SPY001-001

· Spyre Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPY001-001, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SPY001-001 in Healthy Volunteers [Phase 1]